07.23.25
Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
07.30.25
Tryptyr Now Available in US07.16.25
AECOS Presentation SummariesShow More